Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome

Additional Metadata
THEME	Life Sciences (theme 5), Energy (theme 4)
Publisher	Nature Publishing Group
Journal	British Journal of Cancer
Organisation	Evolutionary Intelligence
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Schramm, A., Schowe, B., Fielitz, K., Heilmann, M., Martin, M., Marschall, T., Köster, J., Vandesompele, J., Vermeulen, J., de Preter, K., Koster, J., Versteeg, R., Noguera, R., Speleman, F., Rahmann, S., Eggert, A., Morik, A.& Schulte, J. (2012). Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome. British Journal of Cancer, 107, 1409–1417.

Additional Files
Publisher Version

Publication